Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $35.48B | $320.30 | 2.98% | $318.03M | 6,406.00x | 0.85 | Cayman Islands | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $244.88B | $55.11 | 5.19% | $24.81B | 15.33x | 2.02 | Denmark | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $52.56B | $397.83 | -0.58% | $151.92M | 1,283.32x | 19.74 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $3.11B | $41.06 | -2.25% | $53.58M | 83.80x | 0.33 | Bermuda | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $469.52M | $8.34 | 0.00% | $67.21M | 17.38x | 1.03 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $3.68B | $34.95 | -8.51% | $65.98M | 34.95x | 0.30 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.88B | $37.08 | 4.13% | $29.31M | 142.62x | 0.41 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $48.88B | $800.88 | -4.66% | $811.30M | 32.00x | 0.18 | Belgium | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $7.10B | $244.71 | -0.89% | $193.29M | 35.47x | 0.09 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.82B | $63.03 | 5.67% | $220.90M | 126.06x | 0.29 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $20.42B | $31.80 | -0.06% | $2.00B | 13.57x | 0.22 | Denmark | ||
| ABEO | ABEONA THERAPEUTICS INC | NASDAQ | Biotechnology | $282.88M | $5.22 | -1.69% | $89.85M | 3.28x | 0.35 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $4.29B | $18.03 | 0.84% | $172.13M | 20.49x | 0.32 | United States | ||
| XOMA | XOMA ROYALTY CORP | NASDAQ | Biotechnology | $329.64M | $26.62 | -4.89% | $26.75M | 32.86x | 1.77 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.02B | $15.30 | -0.33% | $103.52M | 26.38x | 0.44 | Canada | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $3.45B | $43.63 | 2.93% | $57.00M | 111.87x | 0.09 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.78B | $192.03 | 1.01% | $103.01M | 83.13x | 0.55 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $960.44M | $12.19 | 0.25% | $112.26M | 5.37x | 1.01 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.73B | $5.62 | 0.36% | $73.18M | 56.20x | -12.10 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $514.75M | $6.45 | 3.20% | $22.69M | 23.89x | 0.39 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $22.89B | $39.65 | 2.03% | $1.04B | 22.53x | 1.01 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.37B | $42.40 | -2.71% | $927.60M | 17.24x | 0.31 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $113.87B | $448.80 | -0.74% | $4.66B | 31.36x | 0.44 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $143.95M | $1.79 | 2.87% | $8.87M | 25.57x | 0.56 | Israel | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.31B | $58.87 | -0.98% | $772.70M | 21.64x | 0.26 | United States | ||
| APLS | APELLIS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.15B | $24.87 | -3.83% | $93.37M | 71.06x | 1.64 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.37B | $71.20 | 1.27% | $845.48M | 14.56x | 3.41 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.12B | $36.75 | -1.69% | $269.64M | 11.38x | 0.45 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.80B | $22.80 | -1.51% | $323.88M | 12.74x | 0.14 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $80.22B | $763.23 | -1.68% | $5.71B | 17.57x | 0.30 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $937.49M | $6.33 | -2.31% | $69.21M | 22.61x | 0.34 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.50B | $20.03 | 0.81% | $214.76M | 10.60x | 0.42 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $21.08B | $489.69 | -1.42% | $1.77B | 17.19x | 0.12 | United States | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $4.42B | $26.15 | -0.53% | $287.72M | 16.66x | 0.45 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $19.98B | $101.79 | 0.36% | $1.68B | 16.85x | 0.36 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.